Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.

NCT00151788 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

796

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis
Heterozygous Familial Hypercholesterolemia

Interventions

DRUG: Pactimibe sulfate

Sponsor

Daiichi Sankyo